Charanjit S. Rihal

Charanjit S. Rihal

Auto-generated profile, based on publicly available information

Charanjit S. Rihal

Mayo Clinic

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2004 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
KBKevin A. Bybee
Kevin A. Bybee
TKTomas Kara
Tomas Kara
APAbhiram Prasad
Abhiram Prasad
ALAmir Lerman
Amir Lerman
GBGreg W. Barsness
Greg W. Barsness
CRCharanjit S. Rihal
Charanjit S. Rihal
The transient left ventricular apical ballooning syndrome, also known as takotsubo cardiomyopathy, is characterized by transient wall-motion abnormalities involving the left ventricular apex and mid-ventricle in the absence of obstructive epicardial coronary disease. In this paper, we review case series that report on patients with the transient left ventricular apical ballooning syndrome to better characterize patients presenting with the syndrome. We identified 7 case series that reported on at least 5 consecutive patients with the transient left ventricular apical ballooning syndrome. The syndrome more often affects postmenopausal women (82% to 100%) (mean age, 62 to 75 years). Patients commonly present with ST-segment elevation in the precordial leads, chest pain, relatively minor elevation of cardiac enzyme and biomarker levels, and transient apical systolic left ventricular dysfunction despite the absence of obstructive epicardial coronary disease. An episode of emotional or physiologic stress frequently precedes presentation with the syndrome. The in-hospital mortality rate seems to be low, as does the risk for recurrence.

1 May 2015 in JACC
Verified
Journal Article
Closed access
CRCharanjit S. Rihal
Charanjit S. Rihal
SNSrihari S. Naidu
Srihari S. Naidu
MGMichael M. Givertz
Michael M. Givertz
WSWilson Y. Szeto
Wilson Y. Szeto
JBJames A. Burke
James A. Burke
TTThomas Tu
Thomas Tu

11 March 2005 in European Heart Journal
Verified
Journal Article
Open access
PDF file
JAJorge R. Alegria
Jorge R. Alegria
JHJoerg Herrmann
Joerg Herrmann
DHDavid R. Holmes
David R. Holmes
ALAmir Lerman
Amir Lerman
CRCharanjit S. Rihal
Charanjit S. Rihal
Myocardial bridging, a congenital coronary anomaly, is a clinical condition with several possible manifestations, and its clinical relevance is debated. This article reviews current knowledge about the anatomy, pathophysiology, clinical relevance, and treatment of myocardial bridging. Myocardial bridging is present when a segment of a major epicardial coronary artery, the ‘tunnelled artery’, runs intramurally through the myocardium. With each systole, the coronary artery is compressed. Myocardial bridging has been associated with angina, arrhythmia, depressed left ventricular function, myocardial stunning, early death after cardiac transplantation, and sudden death. Evidence indicates that the intima beneath the bridge is protected from atherosclerosis, and the proximal segment is more susceptible to development of atherosclerotic lesions because of haemodynamic disturbances. New techniques (e.g. intravascular ultrasonography and intracoronary Doppler studies) have revealed new characteristics and pathophysiologic processes such as diastolic flow abnormalities. Medical treatment generally includes β-blockers. Nitrates should be avoided because symptoms may worsen. Intracoronary stents and surgery have been attempted in selected patients. Additional research is needed to define patients in whom myocardial bridging is potentially pathologic, and randomized multicentre long-term follow-up studies are needed to assess the natural history, patient selection, and therapeutic approaches.

1 July 2021 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
MAMohammed Al-Hijji
Mohammed Al-Hijji
ASAbdallah El Sabbagh
Abdallah El Sabbagh
SHStephanie El Hajj
Stephanie El Hajj
MAMohamad AlKhouli
Mohamad AlKhouli
BSBassim El Sabawi
Bassim El Sabawi
CRCharanjit S. Rihal
Charanjit S. Rihal

1 February 2012 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
CRCharanjit S. Rihal
Charanjit S. Rihal
PSPaul Sorajja
Paul Sorajja
JBJeffrey D. Booker
Jeffrey D. Booker
DHDonald J. Hagler
Donald J. Hagler
ACAllison K. Cabalka
Allison K. Cabalka